<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prescribing Advice for GPs</title>
	<atom:link href="http://www.prescriber.org.uk/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.prescriber.org.uk</link>
	<description>An NHS Prescribing Advisers&#039; Blog</description>
	<lastBuildDate>Tue, 16 Mar 2010 10:35:11 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>BNF 59</title>
		<link>http://www.prescriber.org.uk/2010/03/bnf-59/</link>
		<comments>http://www.prescriber.org.uk/2010/03/bnf-59/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 10:35:11 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=907</guid>
		<description><![CDATA[The 59th Edition of the British National Formulary is currently being printed and distributed.
New or revised content in this version includes updated advice regarding:

Withdrawal of sibutramine
Community-acquired pneumonia
Safe use of cytotoxic medicines
Azathioprine and thiopurine methyltransferase (TPMT) testing
Prescribing and dispensing of ciclosporin by brand name

Additionally, in this version prescribing information for hepatic and renal impairment, pregnancy, and [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/bnf-59/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prevention of diabetes</title>
		<link>http://www.prescriber.org.uk/2010/03/prevention-of-diabetes/</link>
		<comments>http://www.prescriber.org.uk/2010/03/prevention-of-diabetes/#comments</comments>
		<pubDate>Mon, 15 Mar 2010 15:29:10 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=906</guid>
		<description><![CDATA[The New England Journal of Medicine has published the results of two studies that aimed to assess the efficacy of medication on the incidence of diabetes and cardiovascular events. The results of these studies have been reported in the general media (BBC).
Although the results are published as two papers the study was a single trial [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/prevention-of-diabetes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Episodic hypertension and stroke risk</title>
		<link>http://www.prescriber.org.uk/2010/03/episodic-hypertension-and-stroke-risk/</link>
		<comments>http://www.prescriber.org.uk/2010/03/episodic-hypertension-and-stroke-risk/#comments</comments>
		<pubDate>Fri, 12 Mar 2010 13:20:37 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=905</guid>
		<description><![CDATA[The Lancet has published the results of an analysis that has identified a correlation between stroke risk and variability or maximal in systolic blood pressure (SBP). This study has been reported in the general media (BBC).
The study noted that guidelines for the treatment and diagnosis of hypertension focus upon assessment of blood pressure over a [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/episodic-hypertension-and-stroke-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>No Smoking Day &#8211; 2010</title>
		<link>http://www.prescriber.org.uk/2010/03/no-smoking-day-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/03/no-smoking-day-2010/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 09:00:39 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=904</guid>
		<description><![CDATA[Today is No Smoking Day and this year the theme is WeQuit.
The web site contains information and resources to help people quit smoking. This year there is also an increase in use of internet and technology solutions such as a video blog, Twitter and Facebook pages and even an App for the iPhone that counts [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/no-smoking-day-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Safety Update &#8211; March 2010</title>
		<link>http://www.prescriber.org.uk/2010/03/drug-safety-update-march-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/03/drug-safety-update-march-2010/#comments</comments>
		<pubDate>Tue, 09 Mar 2010 11:14:47 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=903</guid>
		<description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for March 2010 (PDF).
This issue contains drug safety advice regarding a possible small increase in the risk of congenital cardiac defects when fluoxetine is taken early in pregnancy. This information comes from an analysis of epidemiological data from seven cohort studies. The [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/drug-safety-update-march-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SMC Update &#8211; March 2010</title>
		<link>http://www.prescriber.org.uk/2010/03/smc-update-march-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/03/smc-update-march-2010/#comments</comments>
		<pubDate>Mon, 08 Mar 2010 16:28:16 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=902</guid>
		<description><![CDATA[The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.
Ketoprofen and omeprazole (Axorid&#174;) has been rejected for the symptomatic treatment of rheumatoid arthritis, ankylosing spondylitis and osteoarthritis in patients with a previous history or who are at risk of developing NSAID associated ulcers or erosions in whom continued treatment with ketoprofen is [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/smc-update-march-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Aspirin ineffective in those with low ABI</title>
		<link>http://www.prescriber.org.uk/2010/03/aspirin-ineffective-in-those-with-low-abi/</link>
		<comments>http://www.prescriber.org.uk/2010/03/aspirin-ineffective-in-those-with-low-abi/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 15:38:05 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=901</guid>
		<description><![CDATA[The Journal of the American Medical Association (JAMA) has published the results of a study that aimed to assess the efficacy of aspirin in preventing primary cardiovascular events in patients with a low ankle brachial index (ABI).
ABI is the ratio of systolic blood pressure at the ankle and arm. ABI is used to diagnose peripheral [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/aspirin-ineffective-in-those-with-low-abi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Peer pressure blamed for excessive drinking</title>
		<link>http://www.prescriber.org.uk/2010/03/peer-pressure-blamed-for-excessive-drinking/</link>
		<comments>http://www.prescriber.org.uk/2010/03/peer-pressure-blamed-for-excessive-drinking/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 11:54:39 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=900</guid>
		<description><![CDATA[The Department of Health (DH) has published the results of a survey into the drinking habits of more than 2,000 English adults.
The survey found that 22% of respondents have drunk more alcohol than they planned because of peer pressure. 39% stated that they made up an excuse or lied to avoid another drink.
However, the survey [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/peer-pressure-blamed-for-excessive-drinking/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Rosiglitazone heart risks were hidden</title>
		<link>http://www.prescriber.org.uk/2010/03/rosiglitazone-heart-risks-were-hidden/</link>
		<comments>http://www.prescriber.org.uk/2010/03/rosiglitazone-heart-risks-were-hidden/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 13:24:07 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=899</guid>
		<description><![CDATA[According to the findings of a report prepared by the United States Senate Committee on Finance the manufacturer of rosiglitazone failed to warn patients or regulatory authorities of cardiovascular concerns. This publication has been reported in the British Medical Journal.
A two year investigation has reviewed over 250,000 documents submitted by GlaxoSmithKline, the Food and Drugs [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/03/rosiglitazone-heart-risks-were-hidden/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NICE Guidance &#8211; February 2010</title>
		<link>http://www.prescriber.org.uk/2010/02/nice-guidance-february-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/02/nice-guidance-february-2010/#comments</comments>
		<pubDate>Wed, 24 Feb 2010 09:53:05 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=898</guid>
		<description><![CDATA[The National Institute of Health and Clinical Excellence has published new guidance for the month of February 2010.
There is one guidance document that has an impact in primary care. Public health guidance has been published regarding school-based interventions to prevent the uptake of smoking among children.
This guidance recommends that information on smoking is integrated into [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/nice-guidance-february-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CKS Update – February 2010</title>
		<link>http://www.prescriber.org.uk/2010/02/cks-update-%e2%80%93-february-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/02/cks-update-%e2%80%93-february-2010/#comments</comments>
		<pubDate>Tue, 23 Feb 2010 09:55:10 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=897</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been updated in February 2010 for the following clinical areas:

Depression
Ectopic pregnancy (new)
Glandular Fever (new)
Itch &#8211; widespread (new)
Miscarriage (new)
Neck Lump (new)
Scrotal swellings (new)

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.
]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/cks-update-%e2%80%93-february-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Homeopathy a waste of NHS money</title>
		<link>http://www.prescriber.org.uk/2010/02/homeopathy-a-waste-of-nhs-money/</link>
		<comments>http://www.prescriber.org.uk/2010/02/homeopathy-a-waste-of-nhs-money/#comments</comments>
		<pubDate>Mon, 22 Feb 2010 15:41:44 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=896</guid>
		<description><![CDATA[The Commons Science and Technology Committee has recommended that the NHS should cease funding homeopathy after a review of the available evidence for efficacy. This recommendation has been reported in the general media (BBC).
The committee aims to assess if Government policy is backed by sound scientific evidence. The committee found no evidence that homeopathy works [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/homeopathy-a-waste-of-nhs-money/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Statins and diabetes risk</title>
		<link>http://www.prescriber.org.uk/2010/02/statins-and-diabetes-risk/</link>
		<comments>http://www.prescriber.org.uk/2010/02/statins-and-diabetes-risk/#comments</comments>
		<pubDate>Wed, 17 Feb 2010 11:33:51 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=895</guid>
		<description><![CDATA[The Lancet has published the results of a meta-analysis of randomised statin trials with the aim of establishing whether any association exists between statin use and development of diabetes. This analysis has been reported in the general media (BBC).
This analysis included data from 13 trials involving 91,140 participants. 4,278 participants developed diabetes during the trial [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/statins-and-diabetes-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pandemic Flu Service closed</title>
		<link>http://www.prescriber.org.uk/2010/02/pandemic-flu-service-closed/</link>
		<comments>http://www.prescriber.org.uk/2010/02/pandemic-flu-service-closed/#comments</comments>
		<pubDate>Thu, 11 Feb 2010 11:29:44 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=894</guid>
		<description><![CDATA[The NHS Pandemic Flu Service has been closed in response to the decline in swine flu cases. The closure of the service has been reported in the general media (BBC).
The telephone service and web based assessment tool have both been suspended but could be reinstated within seven days if needed. Patients who suspect that they [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/pandemic-flu-service-closed/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SMC Update – February 2010</title>
		<link>http://www.prescriber.org.uk/2010/02/smc-update-%e2%80%93-february-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/02/smc-update-%e2%80%93-february-2010/#comments</comments>
		<pubDate>Wed, 10 Feb 2010 10:24:27 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=893</guid>
		<description><![CDATA[The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.
Trospium chloride (Flotros&#174;) has been accepted for the symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder. It is noted that this product is a lower cost alternative to an existing trospium preparation. [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/smc-update-%e2%80%93-february-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Safety Update – February 2010</title>
		<link>http://www.prescriber.org.uk/2010/02/drug-safety-update-%e2%80%93-february-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/02/drug-safety-update-%e2%80%93-february-2010/#comments</comments>
		<pubDate>Tue, 09 Feb 2010 09:53:37 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=892</guid>
		<description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for February 2010 (PDF).
This issue contains drug safety advice informing clinicians about a new oral liquid formulation of tacrolimus (Modigraf&#174;) with particular attention drawn to the requirement of careful monitoring if switching formulation.
The Yellow Card update section notifies readers of a recent [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/drug-safety-update-%e2%80%93-february-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cost-efficacy of blood glucose monitoring</title>
		<link>http://www.prescriber.org.uk/2010/02/cost-efficacy-of-blood-glucose-monitoring/</link>
		<comments>http://www.prescriber.org.uk/2010/02/cost-efficacy-of-blood-glucose-monitoring/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 16:40:16 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=891</guid>
		<description><![CDATA[The Journal of the Canadian Medical Association has published a cost-efficacy analysis of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin.
Data from the United Kingdom Prospective Diabetes Study (UKPDS) was used to forecast diabetes-related complications based upon a modest reduction of 0.25% in HbA1c that could be expected in [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/cost-efficacy-of-blood-glucose-monitoring/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lancet retracts Wakefield paper</title>
		<link>http://www.prescriber.org.uk/2010/02/lancet-retracts-wakefield-paper/</link>
		<comments>http://www.prescriber.org.uk/2010/02/lancet-retracts-wakefield-paper/#comments</comments>
		<pubDate>Thu, 04 Feb 2010 11:26:05 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=890</guid>
		<description><![CDATA[The Lancet has issued a full retraction of the Early Report title &#8220;Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children&#8220;. This is the paper widely credited with raising concerns with the safety of the MMR vaccination.
The paper was partly retracted in 2004 when 10 of the 12 original authors wished to &#8220;make it [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/lancet-retracts-wakefield-paper/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smokefree future</title>
		<link>http://www.prescriber.org.uk/2010/02/smokefree-future/</link>
		<comments>http://www.prescriber.org.uk/2010/02/smokefree-future/#comments</comments>
		<pubDate>Mon, 01 Feb 2010 13:26:20 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=889</guid>
		<description><![CDATA[The Department of Health (DH) has announced an ambitious strategy to halve the number of smokers by 2020.
More than 80,000 deaths each year are linked to smoking and smoking related illnesses costs the NHS £2.7 billion a year. Additionally, the DH notes that research has shown that 7 in 10 smokers want to quit.
The DH [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/02/smokefree-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cohort analysis of HbA1c</title>
		<link>http://www.prescriber.org.uk/2010/01/cohort-analysis-of-hba1c/</link>
		<comments>http://www.prescriber.org.uk/2010/01/cohort-analysis-of-hba1c/#comments</comments>
		<pubDate>Fri, 29 Jan 2010 11:50:46 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=888</guid>
		<description><![CDATA[The Lancet has published the results of an observational retrospective cohort study that aimed to assess the relationship between HbA1c and all-cause mortality. The study is accompanied by a comment article that discusses the findings further.
The study collected data from the UK General Practice Research Database for 27,965 individuals aged 50 years and older with [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/01/cohort-analysis-of-hba1c/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NICE Guidance &#8211; January 2010</title>
		<link>http://www.prescriber.org.uk/2010/01/nice-guidance-january-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/01/nice-guidance-january-2010/#comments</comments>
		<pubDate>Wed, 27 Jan 2010 10:51:06 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=887</guid>
		<description><![CDATA[The National Institute of Health and Clinical Excellence has published new guidance for the month of January 2010.
There is one guidance document that has an impact in primary care. The clinical guideline for venous thromboembolism &#8211; reducing the risk (QRG) has been updated. The scope of the previous guideline has been extended to cover all [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/01/nice-guidance-january-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CKS Update &#8211; January 2010</title>
		<link>http://www.prescriber.org.uk/2010/01/cks-update-january-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/01/cks-update-january-2010/#comments</comments>
		<pubDate>Tue, 26 Jan 2010 10:58:45 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=886</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been updated in January 2010 for the following clinical areas:

Colorectal screening (new)
Halitosis (new)
Hirsutism (new)
Lyme Disease (new)
Osgood-Schlatter&#8217;s disease (new)
Urinary tract infection (lower) &#8211; men

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.
]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/01/cks-update-january-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sibutramine licence suspended</title>
		<link>http://www.prescriber.org.uk/2010/01/sibutramine-licence-suspended/</link>
		<comments>http://www.prescriber.org.uk/2010/01/sibutramine-licence-suspended/#comments</comments>
		<pubDate>Mon, 25 Jan 2010 08:30:55 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=885</guid>
		<description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the suspension of the licence for sibutramine (Reductil&#174;), a weight loss medication recommended as an adjunctive therapy within a weight management programme.
Additional documentation (Press release and Q&#038;A) is available on the European Medicines Agency (EMA) website. Recent study results have linked this medication with an [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/01/sibutramine-licence-suspended/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MeReC Bulletin &#8211; Management of osteoporosis</title>
		<link>http://www.prescriber.org.uk/2010/01/merec-bulletin-management-of-osteoporosis/</link>
		<comments>http://www.prescriber.org.uk/2010/01/merec-bulletin-management-of-osteoporosis/#comments</comments>
		<pubDate>Fri, 22 Jan 2010 09:01:06 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=883</guid>
		<description><![CDATA[The National Prescribing Centre (NPC) has published a MeReC Bulletin (PDF) that describes the management of a postmenopausal woman with risk factors for osteoporosis.
The bulletin adopts a case study format and explores the management of osteoporosis in postmenopausal women. Consideration is given to risk factors for osteoporosis, when to refer for DXA investigation, what dietary [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/01/merec-bulletin-management-of-osteoporosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MeReC Extra 43</title>
		<link>http://www.prescriber.org.uk/2010/01/merec-extra-43/</link>
		<comments>http://www.prescriber.org.uk/2010/01/merec-extra-43/#comments</comments>
		<pubDate>Thu, 21 Jan 2010 14:08:59 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=882</guid>
		<description><![CDATA[The National Prescribing Centre has published MeReC Extra 43 (PDF) which contains an update on the current evidence regarding the clinical significance of the interaction between clopidogrel and proton pump inhibitors (PPIs) and details from two new studies in chronic obstructive pulmonary disease (COPD).
The antithrombotic effect of clopidogrel has been shown to be attenuated by [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/01/merec-extra-43/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
